TY - JOUR
T1 - Comparison of Synthetic Neuronal Model Membrane Mimics in Amyloid Aggregation at Atomic Resolution
AU - Bera, Swapna
AU - Gayen, Nilanjan
AU - Mohid, Sk Abdul
AU - Bhattacharyya, Dipita
AU - Krishnamoorthy, Janarthanan
AU - Sarkar, Dibakar
AU - Choi, Jihye
AU - Sahoo, Nirakar
AU - Mandal, Atin K.
AU - Lee, Dong Kuk
AU - Bhunia, Anirban
N1 - Publisher Copyright:
© 2020 American Chemical Society.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Alzheimer's disease (AD) is a severe neurodegenerative disorder caused by abnormal accumulation of toxic amyloid plaques of the amyloid-beta (Aβ) or the tau proteins in the brain. The plaque deposition leading to the collapse of the cellular integrity is responsible for a myriad of surface phenomena acting at the neuronal lipid interface. Recent years have witnessed dysfunction of the blood-brain barriers (BBB) associated with AD. Several studies support the idea that BBB acts as a platform for the formation of misfolded Aβ peptide, promoting oligomerization and fibrillation, compromising the overall integrity of the central nervous system. While the amyloid plaque deposition has been known to be responsible for the collapse of the BBB membrane integrity, the causal effect relationship between BBB and Aβ amyloidogenesis remains unclear. In this study, we have used physiologically relevant synthetic model membrane systems to gain atomic insight into the functional aspects of the lipid interface. Here, we have used a minimalist BBB mimic, POPC/POPG/cholesterol/GM1, to compare with the native BBB (total lipid brain extract (TLBE)), to understand the molecular events occurring in the membrane-induced Aβ40 amyloid aggregation. Our study showed that the two membrane models accelerated the Aβ40 aggregation kinetics with differential secondary structural transitions of the peptide. The observed structural transitions are defined by the lipid compositions, which in turn undermines the differences in lipid surface phenomena, leading to peptide induced cellular toxicity in the neuronal membrane.
AB - Alzheimer's disease (AD) is a severe neurodegenerative disorder caused by abnormal accumulation of toxic amyloid plaques of the amyloid-beta (Aβ) or the tau proteins in the brain. The plaque deposition leading to the collapse of the cellular integrity is responsible for a myriad of surface phenomena acting at the neuronal lipid interface. Recent years have witnessed dysfunction of the blood-brain barriers (BBB) associated with AD. Several studies support the idea that BBB acts as a platform for the formation of misfolded Aβ peptide, promoting oligomerization and fibrillation, compromising the overall integrity of the central nervous system. While the amyloid plaque deposition has been known to be responsible for the collapse of the BBB membrane integrity, the causal effect relationship between BBB and Aβ amyloidogenesis remains unclear. In this study, we have used physiologically relevant synthetic model membrane systems to gain atomic insight into the functional aspects of the lipid interface. Here, we have used a minimalist BBB mimic, POPC/POPG/cholesterol/GM1, to compare with the native BBB (total lipid brain extract (TLBE)), to understand the molecular events occurring in the membrane-induced Aβ40 amyloid aggregation. Our study showed that the two membrane models accelerated the Aβ40 aggregation kinetics with differential secondary structural transitions of the peptide. The observed structural transitions are defined by the lipid compositions, which in turn undermines the differences in lipid surface phenomena, leading to peptide induced cellular toxicity in the neuronal membrane.
KW - Amyloid beta
KW - blood-brain barrier
KW - fluorescence
KW - NMR
KW - protein aggregation
KW - relaxation
KW - total brain lipid extract
UR - http://www.scopus.com/inward/record.url?scp=85087469323&partnerID=8YFLogxK
U2 - 10.1021/acschemneuro.0c00166
DO - 10.1021/acschemneuro.0c00166
M3 - Article
C2 - 32492332
AN - SCOPUS:85087469323
SN - 1948-7193
VL - 11
SP - 1965
EP - 1977
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
IS - 13
ER -